COVID Vaccines Expanding To 1-C Group
The state will move to vaccinations for the 1-C group next week. That opens eligibility to those 16 years or older at high risk for COVID complications. This includes current cancer treatment, chronic renal disease, COPD, pulmonary fibrosis, cystic fibrosis, moderate or severe asthma, obesity, heart failure, hypertension, sickle cell disease, thalassemia, diabetes, cerebrovascular disease […]
